Jazz Pharmaceuticals plc
JAZZUS売上高
$4.3B
百万USD
営業利益
$-430M
百万USD
純利益
$-356M
百万USD
ROE
-8.2%
最新FY
EPS
$-5.84
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $608M | $122M | $2.09 |
| FY2021 | Q2 | $752M | $-363M | $-6.11 |
| FY2021 | Q3 | $838M | $-53M | $-0.86 |
| FY2021 | FY | $3.1B | $-330M | $-5.52 |
| FY2022 | Q1 | $814M | $2M | $0.03 |
| FY2022 | Q2 | $933M | $35M | $0.55 |
| FY2022 | Q3 | $941M | $-20M | $-0.31 |
| FY2022 | FY | $3.7B | $-224M | $-3.58 |
| FY2023 | Q1 | $893M | $69M | $1.04 |
| FY2023 | Q2 | $957M | $104M | $1.52 |
| FY2023 | Q3 | $972M | $147M | $2.14 |
| FY2023 | FY | $3.8B | $415M | $6.10 |
| FY2024 | Q1 | $902M | $-15M | $-0.23 |
| FY2024 | Q2 | $1.0B | $169M | $2.49 |
| FY2024 | Q3 | $1.1B | $215M | $3.42 |
| FY2024 | FY | $4.1B | $560M | $8.65 |
| FY2025 | Q1 | $898M | $-93M | $-1.52 |
| FY2025 | Q2 | $1.0B | $-718M | $-11.74 |
| FY2025 | Q3 | $1.1B | $251M | $4.08 |
| FY2025 | FY | $4.3B | $-356M | $-5.84 |
| FY2026 | Q1 | $1.1B | $293M | $4.43 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $1.9B | $2.2B | $2.4B | $3.1B | $3.7B | $3.8B | $4.1B | $4.3B |
| 営業利益 | $592M | $529M | $615M | $532M | $378M | $170M | $-66M | $579M | $717M | $-430M |
| 純利益 | $397M | $488M | $447M | $523M | $239M | $-330M | $-224M | $415M | $560M | $-356M |
| 総資産 | $4.8B | $5.1B | $5.2B | $5.5B | $6.5B | $12.3B | $10.8B | $11.4B | $12.0B | $11.7B |
| 純資産 | $1.9B | $2.7B | $2.8B | - | - | - | - | - | - | - |
| 自己資本 | - | $2.7B | $2.8B | $3.1B | $3.7B | $4.0B | $3.1B | $3.7B | $4.1B | $4.3B |
| 営業CF | $591M | $693M | $799M | $776M | $900M | $779M | $1.3B | $1.1B | $1.4B | $1.4B |
| EPS | $6.41 | $7.96 | $7.30 | $9.09 | $4.22 | $-5.52 | $-3.58 | $6.10 | $8.65 | $-5.84 |
| BPS | - | $45.37 | $48.33 | $56.21 | $64.33 | $63.64 | $48.21 | $59.28 | $66.42 | $68.83 |
| ROE | - | 18.0% | 16.2% | 16.8% | 6.5% | -8.3% | -7.3% | 11.1% | 13.7% | -8.2% |